169 related articles for article (PubMed ID: 23771610)
1. Effect of daptomycin on local interleukin-6, matrix metalloproteinase-9, and metallopeptidase inhibitor 1 in patients with MRSA-infected diabetic foot.
Ambrosch A; Halevy D; Fwity B; Brin T; Lobmann R
Int J Low Extrem Wounds; 2013 Jun; 12(2):100-5. PubMed ID: 23771610
[TBL] [Abstract][Full Text] [Related]
2. Effect of daptomycin on local interleukin-6, matrix metalloproteinase-9, and metallopeptidase inhibitor 1 in patients with MRSA-infected diabetic foot.
Ambrosch A; Halevy D; Fwity B; Brin T; Lobmann R
Int J Low Extrem Wounds; 2014 Mar; 13(1):12-6. PubMed ID: 24659622
[TBL] [Abstract][Full Text] [Related]
3. Daptomycin for methicillin-resistant Staphylococcus aureus diabetic foot infections.
Joseph WS; Quast T; Cogo A; Crompton MG; Yoon MJ; Lamp KC; Culshaw D; Chaves RL
J Am Podiatr Med Assoc; 2014 Mar; 104(2):159-68. PubMed ID: 24725036
[TBL] [Abstract][Full Text] [Related]
4. [Risk factors for infections of methicillin-resistant Staphylococci in diabetic foot patients].
Ding Q; Li DQ; Wang PH; Chu YJ; Meng SY; Sun Q
Zhonghua Yi Xue Za Zhi; 2012 Jan; 92(4):228-31. PubMed ID: 22490791
[TBL] [Abstract][Full Text] [Related]
5. Increased ratio of serum matrix metalloproteinase-9 against TIMP-1 predicts poor wound healing in diabetic foot ulcers.
Li Z; Guo S; Yao F; Zhang Y; Li T
J Diabetes Complications; 2013; 27(4):380-2. PubMed ID: 23357650
[TBL] [Abstract][Full Text] [Related]
6. Infections of diabetic foot ulcers with methicillin-resistant Staphylococcus aureus.
Cervantes-García E; García-González R; Reséndiz-Albor A; Salazar-Schettino PM
Int J Low Extrem Wounds; 2015 Mar; 14(1):44-9. PubMed ID: 25573977
[TBL] [Abstract][Full Text] [Related]
7. Implementation of an antimicrobial stewardship pathway with daptomycin for optimal treatment of methicillin-resistant Staphylococcus aureus bacteremia.
Kullar R; Davis SL; Kaye KS; Levine DP; Pogue JM; Rybak MJ
Pharmacotherapy; 2013 Jan; 33(1):3-10. PubMed ID: 23307539
[TBL] [Abstract][Full Text] [Related]
8. [In vitro activity of daptomycin against strains isolated from diabetic foot ulcers].
Sotto A; Laouini D; Bouziges N; Jourdan N; Richard JL; Lavigne JP
Pathol Biol (Paris); 2010 Feb; 58(1):73-7. PubMed ID: 19875242
[TBL] [Abstract][Full Text] [Related]
9. Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin.
French GL
J Antimicrob Chemother; 2006 Dec; 58(6):1107-17. PubMed ID: 17040922
[TBL] [Abstract][Full Text] [Related]
10. Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin.
Skiest DJ
J Clin Microbiol; 2006 Feb; 44(2):655-6. PubMed ID: 16455939
[TBL] [Abstract][Full Text] [Related]
11. Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy.
Falcone M; Russo A; Pompeo ME; Vena A; Marruncheddu L; Ciccaglioni A; Grossi P; Mancini C; Novelli A; Stefani S; Venditti M
Int J Antimicrob Agents; 2012 Jan; 39(1):64-8. PubMed ID: 22047703
[TBL] [Abstract][Full Text] [Related]
12. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.
Mohan SS; McDermott BP; Cunha BA
Heart Lung; 2005; 34(1):69-71. PubMed ID: 15647736
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of daptomycin in complicated skin and skin-structure infections due to methicillin-sensitive and -resistant Staphylococcus aureus: results from the CORE Registry.
Martone WJ; Lamp KC
Curr Med Res Opin; 2006 Dec; 22(12):2337-43. PubMed ID: 17257448
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers.
Richard JL; Sotto A; Jourdan N; Combescure C; Vannereau D; Rodier M; Lavigne JP;
Diabetes Metab; 2008 Sep; 34(4 Pt 1):363-9. PubMed ID: 18632297
[TBL] [Abstract][Full Text] [Related]
15. [Diabetic foot infections. Prevalence and antibiotic sensitivity of the causative microorganisms].
Martínez-Gómez Dde A; Ramírez-Almagro C; Campillo-Soto A; Morales-Cuenca G; Pagán-Ortiz J; Aguayo-Albasini JL
Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):317-21. PubMed ID: 19237227
[TBL] [Abstract][Full Text] [Related]
16. Relationship and susceptibility profile of Staphylococcus aureus infection diabetic foot ulcers with Staphylococcus aureus nasal carriage.
Taha AB
Foot (Edinb); 2013 Mar; 23(1):11-6. PubMed ID: 23266129
[TBL] [Abstract][Full Text] [Related]
17. Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections.
Lipsky BA; Stoutenburgh U
J Antimicrob Chemother; 2005 Feb; 55(2):240-5. PubMed ID: 15659542
[TBL] [Abstract][Full Text] [Related]
18. Methicillin-resistant Staphylococcus aureus in diabetic foot infections.
Eleftheriadou I; Tentolouris N; Argiana V; Jude E; Boulton AJ
Drugs; 2010 Oct; 70(14):1785-97. PubMed ID: 20836573
[TBL] [Abstract][Full Text] [Related]
19. Role of Daptomycin on Burn Wound Healing in an Animal Methicillin-Resistant Staphylococcus aureus Infection Model.
Simonetti O; Lucarini G; Orlando F; Pierpaoli E; Ghiselli R; Provinciali M; Castelli P; Guerrieri M; Di Primio R; Offidani A; Giacometti A; Cirioni O
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696234
[TBL] [Abstract][Full Text] [Related]
20. Methicillin-resistant Staphylococcus aureus: the superbug.
Ippolito G; Leone S; Lauria FN; Nicastri E; Wenzel RP
Int J Infect Dis; 2010 Oct; 14 Suppl 4():S7-11. PubMed ID: 20851011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
